MediFind
Condition

Acute Myeloblastic Leukemia without Maturation

Condition 101

What are the alternative names for Acute Myeloblastic Leukemia without Maturation?

  • Acute myeloblastic leukemia type 1
  • Acute myeloblastic leukemia M1
  • AML M1

Latest Research

Latest Advance
Study
  • Condition: Acute Myeloid Leukemia in Children
  • Journal: Pediatric blood & cancer
  • Treatment Used: Fludarabin, Cytarabine, and Fractioned Gemtuzumab followed by Hematopoietic Stem Cell Transplantation
  • Number of Patients: 8
  • Published —
The study researched the outcomes between fludarabin, cytarabine, and fractioned gemtuzumab followed by hematopoietic stem cell transplantation for children with first-line refractory acute myeloid leukemia.
Latest Advance
Study
  • Condition: Bone Marrow (BM) Haploidentical Transplant
  • Journal: Cytotherapy
  • Treatment Used: Post-Transplantation Cyclophosphamide (PT-CY)
  • Number of Patients: 88
  • Published —
This study analyzed cell content data in patients receiving HLA haploidentical bone marrow (BM) transplants with post-transplantation cyclophosphamide (PT-CY).
Latest Advance
Study
  • Condition: Relapsed myelodisplastic syndrome/acute myeloid leukemia and high-risk acute myeloid leukemia
  • Journal: Zhongguo shi yan xue ye xue za zhi
  • Treatment Used: Decitabine combined with donor lymphocyte infusion
  • Number of Patients: 10
  • Published —
The study researched the effects of decitabine combined with donor lymphocyte infusion for relapsed myelodisplastic syndrome/acute myeloid leukemia and high-risk acute myeloid leukemia.
Latest Advance
Study
  • Condition: Low and Moderate-Risk Myelodysplastic Syndrome (MDS)
  • Journal: Zhongguo shi yan xue ye xue za zhi
  • Treatment Used: Decitabine
  • Number of Patients: 47
  • Published —
This study investigated the effectiveness of decitabine in the treatment of patients with low-risk and moderate-risk myelodysplastic syndrome (MDS) and to analyze the prognostic factors.